Yizhi capsule for vascular dementia - PubMed (original) (raw)

Review

Yizhi capsule for vascular dementia

T X Wu et al. Cochrane Database Syst Rev. 2007.

Abstract

Background: Vascular dementia (VD) is a syndrome or diagnosis that has different causes and clinical manifestations relating to several different vascular mechanisms and changes in the brain. Some traditional Chinese herbal medicines were developed for treating VD. DH: Yizhi capsule is one such herbal concoction which is reported to improve clinical symptoms significantly. The efficacy and adverse effects of Yizhi capsule need to be reviewed systematically and assessed critically to inform clinical practice and guide the continued search for new treatment regimens.

Objectives: To assess the effectiveness and possible adverse events of 'Yizhi capsule' in treating vascular dementia.

Search strategy: The Cochrane Dementia and Cognitive Improvement Group's Specialised Register was searched on 18 September 2006 using the terms yi-zhi, "yi zhi" and yizhi. This database contains trial references from major health care databases and ongoing trial database and is up to date. In addition the review authors searched a variety of Chinese databases.

Selection criteria: Randomised, placebo controlled trials in which patients with vascular dementia were treated with 'Yizhi capsule' were included.

Data collection and analysis: Two authors independently assessed trial quality and extracted data. We telephoned study authors for missing information as to whether treatment allocation was randomised and other methodological details.

Main results: No studies were found that met the inclusion criteria. We identified nine references to trials which included the term 'Yizhi capsule' in the description of the interventions. Two study authors were contacted by telephone and we discovered that the allocation methods they had used were not actually randomised. Four references were describing the same study. Three studies were excluded because 'positive drugs' were used as a control.

Authors' conclusions: There is no evidence from randomised controlled trials to support or proscribe against the use of 'Yizhi capsule' as a treatment for vascular dementia.

PubMed Disclaimer

Conflict of interest statement

None known.

Update of

• doi: 10.1002/14651858.CD005382

Similar articles

• Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
  Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
• Zhiling decoction for vascular dementia.
  Jirong Y, Xiaoyan Y, Taixiang W, Defen S, Birong D. Jirong Y, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004670. doi: 10.1002/14651858.CD004670.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495123 Review.
• [Clinical observation of effect on tongmai yizhi capsule in treating vascular dementia].
  Yan XP, Wang H, Zhang TZ. Yan XP, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001 Aug;21(8):573-5. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001. PMID: 12575567 Clinical Trial. Chinese.
• Chinese herbal medicines for unexplained recurrent miscarriage.
  Li L, Dou L, Leung PC, Chung TK, Wang CC. Li L, et al. Cochrane Database Syst Rev. 2016 Jan 14;2016(1):CD010568. doi: 10.1002/14651858.CD010568.pub2. Cochrane Database Syst Rev. 2016. PMID: 26760986 Free PMC article. Review.
• Chinese herbal medicines for treating osteoporosis.
  Liu Y, Liu JP, Xia Y. Liu Y, et al. Cochrane Database Syst Rev. 2014 Mar 6;2014(3):CD005467. doi: 10.1002/14651858.CD005467.pub2. Cochrane Database Syst Rev. 2014. PMID: 24599707 Free PMC article. Review.

Cited by

• Cerebrolysin for vascular dementia.
  Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cui S, et al. Cochrane Database Syst Rev. 2019 Nov 11;2019(11):CD008900. doi: 10.1002/14651858.CD008900.pub3. Cochrane Database Syst Rev. 2019. PMID: 31710397 Free PMC article.
• Traditional Chinese herbal medicine for vascular dementia.
  Chan ES, Bautista DT, Zhu Y, You Y, Long JT, Li W, Chen C. Chan ES, et al. Cochrane Database Syst Rev. 2018 Dec 6;12(12):CD010284. doi: 10.1002/14651858.CD010284.pub2. Cochrane Database Syst Rev. 2018. PMID: 30520514 Free PMC article.
• Cochrane systematic reviews of Chinese herbal medicines: an overview.
  Hu J, Zhang J, Zhao W, Zhang Y, Zhang L, Shang H. Hu J, et al. PLoS One. 2011;6(12):e28696. doi: 10.1371/journal.pone.0028696. Epub 2011 Dec 9. PLoS One. 2011. PMID: 22174870 Free PMC article. Review.
• The role of phytochemicals in the treatment and prevention of dementia.
  Howes MJ, Perry E. Howes MJ, et al. Drugs Aging. 2011 Jun 1;28(6):439-68. doi: 10.2165/11591310-000000000-00000. Drugs Aging. 2011. PMID: 21639405 Review.
• Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies.
  Manheimer E, Wieland S, Kimbrough E, Cheng K, Berman BM. Manheimer E, et al. J Altern Complement Med. 2009 Sep;15(9):1001-14. doi: 10.1089/acm.2008.0414. J Altern Complement Med. 2009. PMID: 19757977 Free PMC article. Review.

References

References to studies excluded from this review

Chen 1997 {published data only}

1. 1. Chen K, Chen KJ, Zhou WQ, Chui N, Tu RS, Gao P, et al. Yizhi Capsule in the treatment of senile vascular dementia, a randomized trial [Clinical Study of Effect of Yizhi Capsule on Senile Vascular dementia]. Chinese Journal of Integrated traditional Chinese and Western Medicine 1997;17(7):393‐7. - PubMed

Qiao 2004 {published data only}

1. 1. Qiao QZ, Zhang ZQ, Liu HR, Chang ZY. Effect of fushen yizhi capsule on the blood lipid and hemorheology in elderly patients with vascular dementia. Chinese Journal of Clinical Rehabilitation 2004;8(31):6962‐3.

Wang 2000 {published data only}

1. 1. Wang XF, Wang KP, Wang FJ. Yizhi Zaizao capsule in the treatment of vascular dementia with 50 cases. Modern Journal of Integrated Traditional Chinese and Western Medicine 2000;9(14):1373‐4.

Wang 2002 {published data only}

1. 1. Wang FJ, Lu SJ, Dong Z. Yizhi TOngluo capsule in the treatment of vascular dementia. Modern Journal of Integrated Tradtional Chinese and Western Medicine 2002;11(4):295‐7.

Yan 2001 {published data only}

1. 1. Yan XP, Wang H, Zhang TZ. Clinical observation on effect of Tongmai Yizhi capsule in treating vascular dementia. Chinese Journal of Integrated Tradetional Chinese and Western Medicine 2001;21(8):573‐5. - PubMed

Zhang 2004 {published data only}

1. 1. Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi‐infarct dementia. Journal of Fujian College of TCM 2004;14(1):1‐3.
2. 1. Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi‐infarct dementia. Journal of Fujian College of TCM 2004;14(4):1‐3.
3. 1. Ji LJ, Zhang MZ. Qiangpi Bujin Huayu. Yizhi capsule in the treatment of multi‐infarct dementia. Journal of Fujian College of TCM 2004;14(5):1‐3.
4. 1. Zhang MZ, Dong ZX, Mao YJ, Du F. A randomised controlled trial of Yizhi capsule in the treatment of multi‐infarct dementia [Effects of Yi‐zhi capsule on multi‐infarct dementia and intelligence quotient]. Medical Journal of Qilu 2004;19(1):31‐2.
5. 1. Zhang MZ, Dong ZX, Mao YJ, Du F. Effect of yizhi capsule on the intelligence of patient with multi‐infarct dementia. Chinese Journal of Clinical Rehabilitation 2005;9(36):155‐7.

Additional references

Aevarsson 1998

1. 1. Aevarsson O, Svanborg A, Skoog I. Seven‐year survival after age 85 years. Relation to Alzheimer disease and vascular dementia. Archives of Neurology 1998;55:1226‐32. - PubMed

APA 1997

1. 1. American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Journal of Psychiatry 1997;154(5 suppl):1‐39. - PubMed

APA 2000

1. 1. American Psychiatric Association. DSM‐IV criteria for the diagnosis of vascular dementia. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision Washington, DC. Washington, DC: American Psychiatric Association, 2000.

Atkins 1993

1. 1. Atkins D, Psaty BM, Koepsell TD, et al. Cholesterol reduction and the risk for stroke in men: a meta‐analysis of randomized controlled trials. Annals of Internal Medicine 1993;119:136‐45. - PubMed

Chen 1998

1. 1. Chen JC, Min Y, Wang GQ, Wang Y, Ji JM, Zhang Y. Comparing the effect of anti platelet aggregation of Nao An capsule to aspirin. Chinese Journal of Clinical Pharmaology 1998;7(3):144‐5.

Chen 1999

1. 1. Chen KJ. Ligustrazine's chemical and pharmacological property and clinical application. Ligustrazine's chemical and pharmacological property and clinical application. 1st Edition. Beijing: People's Health Publication House, 1999.

Fulder 1996

1. 1. Fulder S. The Handbook of Alternative and Complementary Medicine. Oxford: Oxford University Press, 1996.

Gorelick 1993

1. 1. Gorelick PB, Brody JA, Cohen DC, et al. Risk factors for dementia associated with multiple cerebral infarcts: a case‐control analysis in predominantly African‐American hospital‐based patients. Arch Neurol 1993;28:724‐29. - PubMed

Hebert 1995

1. 1. Hebert R, Brayne C. Epidemiology of vascular dementia. Neuroepidemiology 1995;14(5):240‐57. - PubMed

Ikeda 2001

1. 1. Ikeda M, Hokoishi K, Maki, et al. Increased prevalence of vascular dementia in Japan: A community‐based epidemiological study. Neurology 2001;84(5):461‐7. - PubMed

Jorm 1998

1. 1. Jorm AF, Jolley D. The incidence of dementia: a meta‐analysis. Neurology 1998;51:738‐33. - PubMed

Kalmijn 1997

1. 1. Kalmijn S, Launer LJ, Ott A. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology 1997;42(5):137‐44. - PubMed

Kannayiram 2004

1. 1. Kannayiram Alagiakrishnan, Kamal Masaki. Vascular Dementia. http://www.emedicine.com/med/topic3150.htm. 2004.

Kuller 2005

1. 1. Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C, Kawas C, Breitner JC, Fitzpatrick A, Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 2005;64(9):1548‐52. - PMC - PubMed

Lawrence 1996

1. 1. Lawrence M, Cruickshank K. Hypertension. Prevention of Cardiovascular Disease. Lawrence M, Neil A, Mant D, Fowler G. Oxford: Oxford University Press, 1996.

Li 2004

1. 1. Li AH, Ke KF, Wu XM, Bao SR. Effects of GSRb1, Rb3, Rg1 against ischemic injury of cultured cortical neurons and its mechanism. Journal of Stroke and Neurology 2004;21(3):231‐3.

Liu 2003

1. 1. Liu L, Guo XE, Zhou YQ, Xia JL. Prevalence of dementia in China. Dementia and Geriatric Cognitive Disorders 2003;15(4):226‐30. - PubMed

McKhann 1994

1. 1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS‐ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1994;34:939‐944. - PubMed

Mo 2004

1. 1. Mo SH, Yang YY, Liu N, Li J, Ling ZJ, Xie JP. Effect of Herba Epimedii on the visceral organs in rats by 45Ca transmembrane flow technique. Journal of Chinese Traditional Medicine 2004;2(4):196‐9.

Olin 2000

1. 1. J Olin, Schneider L, Novit A, Luczak S. Hydergine for dementia. Cochrane Database of Systematic Reviews 2000, Issue 3. [Art. No.: CD000359. DOI: 10.1002/14651858.CD000359] - PubMed

Ou 1987

1. 1. Ou XC, Ding JX, Zhang N. Experimental survey of 126 Chinese Medicine antithrombin function. Chinese Traditional and Herbal Drags 1987;18(4):21.

Pohjasvaara 1998a

1. 1. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen H, Vataja R, Kaste M. Clinical determinants of poststroke dementia. Stroke 1998;29:75‐81. - PubMed

Pohjasvaara 1998b

1. 1. Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. Clinical determinants of poststroke dementia. Stroke 1998;29:75‐81. - PubMed

Rands 2008

1. 1. Rands G, Orrell M, Spector AE. Aspirin for vascular dementia. Cochrane Database of Systematic Reviews 2008, Issue 4. - PubMed

Ravaglia 2005

1. 1. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, et al. Incidence and etiology of dementia in a large elderly Italian population. Neurology 2005;64(9):1525‐30. - PubMed

Roman 2003

1. 1. Roman GC. Vascular dementia: distinguishing characteristics, treatment, and prevention. Journal of the American Geriatrics Society 2003;51(5 Suppl Dementia):S296‐304. - PubMed

Schneider 1994

1. 1. Schneider LS, Olin JT. Overview of clinical trials of hydergine in dementia. Archives of Neurology 1994;51(8):787‐98. - PubMed

Skoog 1994

1. 1. Skoog I. Rick factors for vascular dementia: A review. Dementia 1994;5:137‐44. - PubMed

Skoog 1998

1. 1. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998;17(1):2‐9. - PubMed

Sun 2004

1. 1. Sun QX, Hu YE, Guan H, Xia ZQ. Effects of ZDY101, an active component from Zhimu, on rat dementia model produced by intracranial injection of ibotenic acid. Nuclear Techniques 2004;27(4):297‐300.

Takehiko 2002

1. 1. Takehiko Y. Vascular Dementia in Japan. Annals of the New York Academy of Sciences 2002;977:24‐8. - PubMed

Wei 2004

1. 1. Wei PF, Jiao CL, Chen DD. Heshouwu's pharmacological research. Modern Traditional Chinese Medicine 2004;1:57‐8.

WHO 1992

1. 1. World Health Organization. The ICD‐10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Geneva: World Health Organisation, Division of Mental Health, 1992.

References to other published versions of this review

Wu 2007

1. 1. Wu TX, Li QP, Yuan ZY. Yizhi capsule for vascular dementia. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD005382.pub2] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal